PHARMACOKINETICS AND PHARMACODYNAMICS OF CIPROFLOXACIN IN CYSTIC-FIBROSIS PATIENTS

被引：71

作者：

LEBEL, M

BERGERON, MG

VALLEE, F

FISET, C

CHASSE, G

BIGONESSE, P

RIVARD, G

机构：

[1] CHU LAVAL, DEPT PEDIAT, QUEBEC CITY G1V 4G2, QUEBEC, CANADA

[2] UNIV LAVAL, ECOLE PHARM, QUEBEC CITY G1K 7P4, QUEBEC, CANADA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1986年 / 30卷 / 02期

关键词：

D O I：

10.1128/AAC.30.2.260

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：260 / 266

页数：7

共 29 条

[1] CIPROFLOXACIN PHARMACOKINETICS IN PATIENTS WITH CYSTIC-FIBROSIS [J].

BENDER, SW ;

DALHOFF, A ;

SHAH, PM ;

STREHL, R ;

POSSELT, HG .

INFECTION, 1986, 14 (01) :17-21

[2] PHARMACOKINETICS OF 3 ORAL FORMULATIONS OF CIPROFLOXACIN [J].

DAVIS, RL ;

KOUP, JR ;

WILLIAMSWARREN, J ;

WEBER, A ;

SMITH, AL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (01) :74-77

[3] INVITRO ACTIVITY OF CIPROFLOXACIN, A NEW CARBOXYQUINOLINE ANTIMICROBIAL AGENT [J].

ELIOPOULOS, GM ;

GARDELLA, A ;

MOELLERING, RC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :331-335

[4]

GIBALDI M, 1982, PHARMACOKINETICS

[5] SINGLE-DOSE PHARMACOKINETICS OF ORAL CIPROFLOXACIN IN PATIENTS WITH CYSTIC-FIBROSIS [J].

GOLDFARB, J ;

WORMSER, GP ;

INCHIOSA, MA ;

GUIDERI, G ;

DIAZ, M ;

GANDHI, R ;

GOLTZMAN, C ;

MASCIA, AV .

JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (03) :222-226

[6]

HARRISON CJ, 1985, PEDIATR PHARMACOL, V5, P7

[7]

HELLUM KB, 1978, CURRENT CHEMOTHERAPY, V1, P620

[8] PHARMACOKINETICS OF CIPROFLOXACIN AFTER ORAL AND PARENTERAL ADMINISTRATION [J].

HOFFKEN, G ;

LODE, H ;

PRINZING, C ;

BORNER, K ;

KOEPPE, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :375-379

[9]

HOFFLER D, 1984, EUR J CLIN MICROBIOL, V3, P363

[10] THEOPHYLLINE DISPOSITION IN CYSTIC-FIBROSIS [J].

ISLES, A ;

SPINO, M ;

TABACHNIK, E ;

LEVISON, H ;

THIESSEN, J ;

MACLEOD, S .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 127 (04) :417-421

← 1 2 3 →